- Austria (Website)
- Czech Republic (Website)
- Denmark (Website)
- Finland (Website)
- France (Website)
- Germany (Website)
- Italy (Website)
- Ivory Coast
bioMérieux Corporate Website | Pioneering diagnostics
13 January, 2020 bioMérieux submits enhanced BIOFIRE® BCID2 Panel for FDA clearanc...
18 December, 2019 bioMérieux and the Fleming Fund: working together to strengthen d...
22 October, 2019 Third-Quarter 2019 Business Review
04 September, 2019 First-Half 2019 Results
We are honored to have been selected as a supplier in a tender process by the Fleming Fund to tackle Antimicrobial Resistance (AMR) in low and middle-income countries, in Africa and Asia Pacific. This programme aims at improving access to diagnostics and curbing this public health threat.
In December 2019, an outbreak of pneumonia and acute respiratory infection occurred in the city of Wuhan, China.
Diagnostic tests make it possible to confirm or rule out whether the pathogen responsible for the infection is coronavirus COVID-19.